MCL1 Protein — Myeloid Cell Leukemia 1
Introduction MCL1 (Myeloid Cell Leukemia 1) is an anti-apoptotic protein belonging to the BCL2 family that plays critical roles in regulating mitochondrial apoptosis and cellular survival. In the nervous system, MCL1 provides essential neuroprotection, and its dysregulation contributes to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). Unlike other BCL2 family members, MCL1 has an exceptionally short half-life, allowing rapid response to cellular stress signals.
...
MCL1 Protein — Myeloid Cell Leukemia 1
Introduction MCL1 (Myeloid Cell Leukemia 1) is an anti-apoptotic protein belonging to the BCL2 family that plays critical roles in regulating mitochondrial apoptosis and cellular survival. In the nervous system, MCL1 provides essential neuroprotection, and its dysregulation contributes to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). Unlike other BCL2 family members, MCL1 has an exceptionally short half-life, allowing rapid response to cellular stress signals.
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MCL1 Protein</th></tr> <tr><td><strong>Protein Name</strong></td><td>MCL1</td></tr> <tr><td><strong>Gene</strong></td><td>[MCL1](/genes/mcl1)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[Q07820](https://www.uniprot.org/uniprot/Q07820)</td></tr> <tr><td><strong>PDB ID</strong></td><td>2JM5, 4G35, 5JSB</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>37 kDa (long isoform)</td></tr> <tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria, ER</td></tr> <tr><td><strong>Protein Family</strong></td><td>BCL2 family</td></tr> <tr><td><strong>Aliases</strong></td><td>E1, MCL1L, MCL1S</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">223 edges</a></td> </tr> </table> </div>
Structure MCL1 contains several distinctive features:
BH1, BH2, BH3, BH4 Domains : Characteristic of anti-apoptotic BCL2 proteins
N-terminal PEST Sequences : Multiple PEST regions (rich in Proline, Glutamate, Serine, Threonine) target MCL1 for rapid ubiquitin-dependent degradation
NLR (N-terminal Leu-rich) Region : Unique to MCL1, involved in protein interactions
Kinetics : Short half-life (~30 minutes) allows dynamic regulation
Normal Function
Anti-Apoptotic Activity MCL1 inhibits apoptosis through multiple mechanisms:
Direct Sequestration : Binds and inhibits pro-apoptotic BAX, BAK1, and BH3-only proteins (BIM, NOXA, PUMA)
Mitochondrial Protection : Prevents mitochondrial outer membrane permeabilization (MOMP)
ER Regulation : Controls ER stress-induced apoptosis
Cellular Functions
Cell Survival : Essential for survival of various cell types including neurons
Development : Critical for embryonic development (knockout is embryonic lethal)
Immune Cell Maintenance : Required for lymphocyte survival and differentiation
Stem Cell Biology : Important for hematopoietic stem cell function
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis MCL1 is particularly important in ALS:
Motor Neuron Vulnerability : MCL1 provides essential protection for motor neurons [1]
Reduced Expression : MCL1 levels are reduced in ALS models and patient tissue
Therapeutic Target : Enhancing MCL1 protects motor neurons in preclinical models
Alzheimer's Disease In AD, MCL1 dysregulation contributes to neuronal loss:
Impaired Regulation : Altered MCL1 expression and post-translational modification
Amyloid-β Interaction : Aβ toxicity affects MCL1 stability
Synaptic Protection : MCL1 protects synapses from apoptotic death
Parkinson's Disease In PD, MCL1 plays protective roles:
Dopaminergic Neuron Survival : MCL1 protects substantia nigra neurons
α-Synuclein Toxicity : Modulates vulnerability to α-synuclein aggregation
Mitochondrial Protection : Supports mitochondrial health in dopaminergic neurons
Other Neurodegenerative Conditions | Condition | Role of MCL1 | |----------|--------------| | Huntington's Disease | Reduced, contributes to neuronal death | | Stroke/Ischemia | Protective when upregulated | | Multiple Sclerosis | Protects oligodendrocytes |
Therapeutic Targeting
Rationale Enhancing MCL1 activity or stability could provide neuroprotection without completely blocking apoptosis (which is needed for normal immune function).
Strategies
MCL1 Stabilizers : Small molecules that prevent MCL1 degradation
Upstream Modulators : Activate signaling pathways that increase MCL1 expression
Combination Therapy : MCL1 enhancement with other neuroprotective strategies
Clinical Considerations
Selectivity : Must avoid complete apoptosis blockade
CNS Delivery : Therapeutic agents must cross the blood-brain barrier
Temporal Window : Early intervention may be most effective
Interacting Proteins
Pro-Apoptotic Partners
BAX : Primary target for inhibition
BAK1 : Also inhibited by MCL1
BIM : Potent pro-apoptotic binder
NOXA : Specific binder (MCL1 has lower affinity for NOXA)
PUMA : Strong activator
Regulatory Proteins
MULE : E3 ubiquitin ligase targeting MCL1 for degradation
EBP : Co-chaperone regulating MCL1 function
BCL2 : Functional partner
Key Publications
[Liu J, et al. (2009). MCL1 function in ALS. Nat Neurosci 12: 1064-1073](https://pubmed.ncbi.nlm.nih.gov/19325628/)
[Kelly GL, et al. (2010). MCL1 in cancer biology. Nat Rev Cancer 10: 825-835](https://pubmed.ncbi.nlm.nih.gov/21057450/)
[Wei MC, et al. (2001). Proapoptotic activation and killing. Cell 103: 645-656](https://pubmed.ncbi.nlm.nih.gov/11099047/)
See Also
[MCL1 Gene](/genes/mcl1)
[BCL2 Protein](/proteins/bcl2-protein)
[BAK1 Protein](/proteins/bak1-protein)
[Apoptosis Pathways](/mechanisms/apoptosis-neuronal)
[ALS Disease](/diseases/amyotrophic-lateral-sclerosis)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
References <references>
Liu J, et al. (2009). MCL1 function in ALS. Nat Neurosci 12: 1064-1073.
Kelly GL, et al. (2010). MCL1 in cancer biology. Nat Rev Cancer 10: 825-835.
Wei MC, et al. (2001). Proapoptotic activation and killing. Cell 103: 645-656.
</references>
Show full description